161 related articles for article (PubMed ID: 32972793)
1. Distinguishing Benign Renal Tumors with an Oncocytic Gene Expression (ONEX) Classifier.
McGillivray PD; Ueno D; Pooli A; Mendhiratta N; Syed JS; Nguyen KA; Schulam PG; Humphrey PA; Adeniran AJ; Boutros PC; Shuch B
Eur Urol; 2021 Jan; 79(1):107-111. PubMed ID: 32972793
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.
Liu Q; Cornejo KM; Cheng L; Hutchinson L; Wang M; Zhang S; Tomaszewicz K; Cosar EF; Woda BA; Jiang Z
Am J Pathol; 2018 Apr; 188(4):846-852. PubMed ID: 29353061
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
4. Diagnostic utility of amylase α-1A, MOC 31, and
Abouhashem NS; Abdelbary EH; H Abdalla MM; El-Shazly M
Indian J Pathol Microbiol; 2020; 63(3):405-411. PubMed ID: 32769329
[TBL] [Abstract][Full Text] [Related]
5. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
6. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
[TBL] [Abstract][Full Text] [Related]
7. Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
Ruiz-Cordero R; Rao P; Li L; Qi Y; Atherton D; Peng B; Singh RR; Kim TB; Kawakami F; Routbort MJ; Alouch N; Chow CB; Tang X; Lu W; Brimo F; Matin SF; Wood CG; Tannir NM; Wistuba II; Chen K; Wang J; Medeiros LJ; Karam JA; Tamboli P; Sircar K
Mod Pathol; 2019 Nov; 32(11):1698-1707. PubMed ID: 31231128
[TBL] [Abstract][Full Text] [Related]
8. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
9. Hybrid oncocytic/chromophobe renal cell tumours do not display genomic features of chromophobe renal cell carcinomas.
Poté N; Vieillefond A; Couturier J; Arrufat S; Metzger I; Delongchamps NB; Camparo P; Mège-Lechevallier F; Molinié V; Sibony M
Virchows Arch; 2013 Jun; 462(6):633-8. PubMed ID: 23708994
[TBL] [Abstract][Full Text] [Related]
10. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
11. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
12. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
[TBL] [Abstract][Full Text] [Related]
13. Exploring Multiphoton Microscopy as a Novel Tool to Differentiate Chromophobe Renal Cell Carcinoma From Oncocytoma in Fixed Tissue Sections.
Jain M; Robinson BD; Wu B; Khani F; Mukherjee S
Arch Pathol Lab Med; 2018 Mar; 142(3):383-390. PubMed ID: 29219617
[TBL] [Abstract][Full Text] [Related]
14. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
15. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma.
An J; Park CK; Kim M; Joo JW; Cho NH
Virchows Arch; 2021 Mar; 478(3):459-470. PubMed ID: 32816058
[TBL] [Abstract][Full Text] [Related]
16. Oncocytoma-Related Gene Signature to Differentiate Chromophobe Renal Cancer and Oncocytoma Using Machine Learning.
Satter KB; Tran PMH; Tran LKH; Ramsey Z; Pinkerton K; Bai S; Savage NM; Kavuri S; Terris MK; She JX; Purohit S
Cells; 2022 Jan; 11(2):. PubMed ID: 35053403
[TBL] [Abstract][Full Text] [Related]
17. Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma.
Kowalewski A; Szylberg Ł; Tyloch J; Antosik P; Neska-Długosz I; Frąckowski Ł; Tyloch D; Purpurowicz P; Grzanka D
Pathol Oncol Res; 2019 Oct; 25(4):1519-1524. PubMed ID: 30467700
[TBL] [Abstract][Full Text] [Related]
18. A systematic review and meta-analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Morais C; Bernard A; Saunders N; Samaratunga H; Gobe G; Wood S
J Clin Pathol; 2016 Aug; 69(8):661-71. PubMed ID: 26951082
[TBL] [Abstract][Full Text] [Related]
19. LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.
Zheng G; Chaux A; Sharma R; Netto G; Caturegli P
Exp Mol Pathol; 2013 Feb; 94(1):29-32. PubMed ID: 22705098
[TBL] [Abstract][Full Text] [Related]
20. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
[Next] [New Search]